![Benoit Bouche](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benoit Bouche
Algemeen Directeur bij
Pacific Biomarkers, Inc.
Profiel
Benoit Bouche is currently the Chief Executive Officer at Pacific Biomarkers, Inc., the President, Chief Executive Officer & Director at Nexelis Laboratories Canada, Inc., and the Operating Partner at Ampersand Management LLC.
He previously served as the President & Chief Executive Officer at NEOMED-LABS, Inc. and as an Analyst at Puilaetco in 2001.
Actieve functies van Benoit Bouche
| Bedrijven | Functie | Begin |
|---|---|---|
Pacific Biomarkers, Inc.
 Pacific Biomarkers, Inc. Medical SpecialtiesHealth Technology Provides biomarker testing services | Algemeen Directeur | - |
Nexelis Laboratories Canada, Inc.
 Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Operates as a immunology-centric contract research organization | Algemeen Directeur | 01-01-2017 |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Private Equity Investor | 01-04-2022 |
Eerdere bekende functies van Benoit Bouche
| Bedrijven | Functie | Einde |
|---|---|---|
Puilaetco
 Puilaetco Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 05-12-2001 |
NEOMED-LABS, Inc.
 NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
9
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Puilaetco
Puilaetco Investment Banks/BrokersFinance Provides brokerage services | Finance |
NEOMED-LABS, Inc.
NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pacific Biomarkers, Inc.
Pacific Biomarkers, Inc. Medical SpecialtiesHealth Technology Provides biomarker testing services | Health Technology |
Nexelis Laboratories Canada, Inc.
Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Operates as a immunology-centric contract research organization | Health Technology |
Kies MarketScreener 
